Ribometrix
Ribometrix is developing a new class of small-molecule therapeutics that directly target and modulate the function of RNA to treat human diseases.
Total Equity Investment: $45M+
Alert Banner
Alert:NCBiotech's MOVE program wins federal grant to expand biopharma job opportunities for NC’s military community.
Close Search Window
